Welcome to my Neuroendocrine Cancer terms and definitions list providing a source of meanings for acronyms and medical terms, all sourced from top Neuroendocrine Cancer sites.
How to use this list:
1. If your term begins with an A, click on A to find all terms beginning with A. Select your term from the list.
2. For numerical terms, please click on the hashtag (#) symbol in the A to Z strip.
3. The term definition including acronym or abbreviation will be given in full along with any of my published articles containing that term as long as I have tagged it on my website to display in the list.
A
- Abdomen
- Ablation
- Ac-225
- ACE inhibitor
- Achlorhydria
- Acid reflux
- Acromegaly
- Actin
- Acute
- Addison’s disease
- Adenocarcinoma
- Adenoma
- Adhesions
- Adjunctive therapy
- Adjuvant surgery
- Adjuvant therapy
- Adrenal cortex
- Adrenal glands
- Adrenal insufficiency
- Adrenal medulla
- Adrenaline
- Adrenocortical Carcinoma (ACC)
- Adrenocorticotropic Hormone (ACTH)
- Advanced neuroendocrine cancer
- AdVince
- Afinitor
- Aggressive
- Albumin
- Alcohol
- Alcohol flushing reaction
- ALDH2
- Aldosterone
- Allergies
- Alopecia
- Alternative medicine
- Alternative therapies
- American Society of Clinical Oncology (ASCO)
- Amines
- Amino acids
- Amoxicillin
- Ampulla
- Ampulla of Vater
- Amylase
- Analogue (US Analog)
- Anaphylactic shock
- Anaplastic
- Anastomosis
- Androgrens
- Anemia
- Anesthesia
- Angiogenesis
- Angiogenesis inhibitor
- Angiogram
- Angioma
- Anorexia
- Anti-angiogenic therapy
- Antiacids
- Antibiotics
- Antibody
- Anticoagulant
- Antidepressant
- Antiemetic agent
- Antigen
- Antihistamines
- Antineoplastic
- Antineoplastic therapy
- Antioxident
- Anxiety
- Aorta
- Apoptosis
- Appendectomy
- Appendiceal NET
- Appendix
- Apudoma
- Aretha Franklin
- Arrhymia
- Arterial embolization
- Ascending colon
- Ascites
- Aspiration
- Assay
- Asthma
- Ataxia
- Atezolizumab (Tecentriq)
- Atopic dermatitis
- Atrophic gastritis
- ATRX
- Atypical
- Atypical carcinoid tumour
- Autosomal dominant
- Avelumab (Bavencio)
- Avistan
- Axid (Nizatidine)
- Axilla
- Axillary nodes
- AZEDRA
B
- B12
- B3
- BAM
- Barium enema
- Barium swallow
- Barrett’s Esophagus
- Bavencio
- Benign
- Benign NET
- Benign tumour
- Beta emitter
- Bevacizumab
- Bias
- Biased agonist
- Bile
- Bile acid diarrhea
- Bile acid malabsorption
- Bile acid sequestrant
- Bile acids
- Bile duct
- Bile salt
- Biliary
- Biliary tract cancer
- Bilirubin
- Bioavailable
- Biofeedback
- Biological therapy
- Biomarker
- Biopsy
- Bland liver embolization
- Blinded study
- Blood area nitrogen (BUN)
- Blood brain barrier (BBB)
- Blood cells
- Blood clot
- Blood count
- Blood glucose
- Blood test
- Blood thinner
- Blue Book
- Blushing
- Bolus
- Bone marrow
- Bone marrow biopsy and aspiration
- Bone marrow suppression
- Bone metastases
- Bone scan
- Bowel
- Bowel cancer
- Bowel obstruction
- Bowel surgery
- Bradykinin
- Brain serotonin
- Brain tumour
- Breast cancer
- Breast NEN
- Broken capillaries
- Bronchi
- Bronchial
- Bronchial NET
- Bronchiole
- Bronchitis
- Bronchopulmonary Neuroendocrine Neoplasms (BP NEN)
- Bronchoscopy
- Bronchus
- BUN
- Butt dart
- Bypass
C
- C cell
- C-peptide
- CA 19-9
- CA-125
- CA4P
- Cabometyx
- Cabozantinib
- Cachexia
- Calcitonin
- Calcitonin gene-related peptide (CGRP)
- Calcium
- Calorie
- CAM
- Camera pill
- Cancer
- Cancer anger
- Cancer causes
- Cancer grading
- Cancer of unknown primary (CUP)
- Cancer registries
- Cancer research
- Cancer staging
- Cancer surveillance
- Cancer survivor
- Cancerous tumour
- Cancerversary
- Candidiasis
- Capecitabine
- Capecitabine (Xeloda)
- CAPecitabine TEMozolomide (CAPTEM).
- Capsule endoscopy
- CAPTEM
- Carbocaine
- Carbohydrate
- Carboplatin
- Carcinogen
- Carcinoid
- Carcinoid crisis
- Carcinoid heart disease
- Carcinoid rage
- Carcinoid syndrome
- Carcinoid tumour
- Carcinoma
- Cardiopulmonary hemodynamic instability
- Carney complex
- Catecholamines
- CB-839
- CDKN1B
- Cerebellum
- Chemo bath
- Chemotherapy
- Chinese dumplings
- Cholangiocarcinoma
- Cholecalciferol
- Cholestyramine
- Chromaffin cells
- Chromogranin
- Chromogranin A (CgA)
- Chromogranin B (CgB)
- Chromogranin C (CgC)
- Chronic condition
- Cimetidine
- Cisplatin
- Cisplatin/Etoposide
- CLARINET
- Clexane
- Clinical trial
- CLO test
- Cobalamin
- Coeliac disease
- Cognitive behavioural therapies (CBT)
- Colon cancer
- Colon NET
- Colonoscopy
- Colony stimulating factor-1 receptor (CSF-1R)
- Colorectal cancer
- Combretastatin A-4 phosphate (CA4P)
- Cometriq
- Comorbidity
- COMPETE trial
- Complete blood count (CBC)
- Complex regional pain syndrome (CRPS)
- Constipation
- CONTROLNETS
- COR-003
- COR-005
- Core Biopsy
- Coronavirus
- Corticotrophin releasing hormone (CRH)
- Cortisol
- COVID-19
- Creon
- CRN00808
- CRN01941
- Crohn’s Disease
- Cryoablation
- CT enterography
- CT guided aspiration
- CT scan
- Curative surgery
- Cure
- Cushing’s disease
- Cushing’s syndrome
- Cyberchondria
- Cytoreductive
- Cytotoxic
- C‑Reactive Protein (CRP)
D
- DAXX
- Debulking surgery
- Degenerative bone disease
- Depression
- Dermal fibrosis
- Dermatitis
- Desmoplasia
- DEXA scan
- Dexilent
- Dexlansoprazole
- Diabetes
- Diagnosis
- Diarrhea
- Diet
- Differential diagnosis
- Differentiation
- Diffuse hepatic steatosis
- Digestive enzymes
- DIPNECH
- Distal pancreatectomy
- Distant metastatis
- Diverticulitis
- DNA
- DNA methylation-based profiling
- Do no harm
- Doctor Google (Dr. Google)
- Dopamine
- Dopamine receptors
- DOTA-NOC
- DOTA-TATE
- DOTA-TOC
- DP1038
- Dry skin
- DUNE trial
- Duodenal NET (dNET)
- Duodenum
- Durvalumab
- Dysbiosis
E
- Early Diagnosis
- ECG
- Echocardiogram
- Eczema
- Edotreotide
- EGFR
- EKG
- ELECT study
- Electrolytes
- Eliquis (apixaban)
- EMA
- Endocrine
- Endocrine function (pancreas)
- EndolucinBeta
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Endoscopic ultrasound (EUS)
- Endoscopy
- ENETS
- Enterade® advanced oncology formula
- Enterochromaffin cells
- Enterolith
- Enucleation
- EPAS1
- Epi pens
- Epidemiology
- Epidermal growth factor receptor (EGFR)
- Epinephrine
- Erythematotelangiectatic rosacea (ETR)
- Erythrocyte sedimentation rate (ESR)
- Esomeprazole magnesium
- Estrogen
- Ethanol
- Etoposide
- EUS
- Everolimus
- Exocrine cells
- Exocrine function (pancreas)
- Exocrine pancreatic insufficiency
- Explorer PET scan
- External beam radiotherapy
F
- False negative
- False positive
- Familial medullary thyroid cancer (FMTC)
- Familial NET
- Famotidine
- Fasting Gut Endocrine Profile
- Fat malabsorption
- Fat soluble vitamins
- Fatigue
- Fatty liver
- FCarboSt
- Fecal elastase test
- Fecal fat
- FH
- Fibre
- Fibroblast growth factor receptor (FGFR)
- Fight or flight
- Fine needle aspiration (FNA)
- Fluoro-18-L-Dihydroxyphenylalanine
- Fluoropyrimidine
- Fluorouracil (5-FU)
- Flushing
- Focal fatty sparing
- FODMAP
- FOLFIRI
- FOLFOX
- Follicular cell
- Food allergy
- Food and Drug Administration
- Foregut
- Fosbretabulin tromethamine
- Full blood count (FBC)
- Full remission
- Functional tumour
G
- G protein-coupled receptors (GPCR)
- Ga68 PET/CT
- Ga68-DOTA-JR11
- Ga68-DOTANOC
- Ga68-DOTATATE
- Ga68-DOTATOC
- Ga68-FAPI PET/CT
- Ga68-OPS202
- Gallbladder
- Gallium 68 (Ga68)
- Gamma camera
- Gamma knife
- Gastric NET
- Gastrin
- Gastrin pH
- Gastrinoma
- Gastro-entero-pancreatic neuroendocrine tumour (GEP-NET)
- Gastroenterologist
- Gastroesophageal reflux disease (GERD)
- Gastrointestinal NET (GI-NET)
- Gastroscopy
- Generator (radionuclide)
- Genetic testing
- Genetics
- Genito-urinary NET
- Germline genetic mutations
- Glucagon
- Glucagonoma
- Glycated Hemoglobin (A1C)
- Goitre
- Gonadotropin-releasing hormone (GnRH)
- Grade
- Grading
- Granulinoma
- Graves’ disease
- Growth hormone (GH)
- Gut
- Gut Flora
H
- H2 blockers
- H2 receptor antagonist (H2RA)
- Haemangioblastoma
- Haemoglobin (hemoglobin)
- Hashimoto’s disease
- HbA1c
- Head and Neck Cancer
- Heart disease
- Heat intolerance
- Hedinger syndrome
- Helicobacter pylori
- Hemoglobin
- Hepatic arterial embolization
- Hereditary cancer syndrome
- Hereditary pheochromocytoma/paraganglioma syndromes
- High Grade NEC
- High grade neuroendocrine neoplasm (NEN)
- High grade neuroendocrine tumour (NET)
- High-intensity focused ultrasound (HIFU)
- Hindgut
- HIPEC
- Histamine
- Hodgkin lymphoma
- Hormonal crisis
- Hormone therapy
- Hormones
- Hospice care
- Hotspot
- HPA axis
- Hurthle cell neoplasm
- Hydrocele
- Hydrocelectomy
- Hydrogen breath test
- Hydronephrosis
- Hyperadrenergic
- Hypercalcemia
- Hypercortisolism
- Hypergastrinemia
- Hyperglycemia
- Hyperhidrosis
- Hyperinsulinism
- Hyperparathyroidism
- Hypertension
- Hyperthermic intraperitoneal chemotherapy (HIPEC)
- Hyperthryroidism
- Hypervascularity
- Hypocortisolism
- Hypoglycemia
- Hypokalemia
- Hypotension
- Hypothalamus
- Hypothyroidism
I
- IBS
- IBS-C
- IBS-D
- IBS-M
- Ileocecal resection
- Ileum
- Immunotherapy
- Imodium
- Incidence
- Incidental diagnosis
- Incidentaloma
- Incomplete emptying
- Incurable cancer
- Indium 111-pentetreotide
- Inflammatory bowel disease (IBD)
- Inherited Cancer
- Insulin
- Insulin-like growth factor 1 (IGF-1)
- Insulinoma
- Interferon alpha (IFNα)
- Intermediate grade NET
- International Classification of Diseases (ICD)
- International Classification of Diseases for Oncology (ICD-O)
- Intestinal ischaemia
- Intraoperative chemotherapy
- Intraoperative hypertensive crisis
- Intraoperative radiotherapy (IORT)
- Invisible illness
- Iobenguane I 131
- Ipilimumab (Yervoy)
- Irinotecan (Campto)
- Iron Deficiency Anaemia
- Irritable bowel syndrome (IBS)
- Islet cell
- Islet of Langerhams
L
- Lactulose
- Lanreotide
- Lansoprazole
- Laparoscopic surgery
- Large cell neuroendocrine carcinoma (LCNEC)
- Larotrectinib sulfate
- Late Diagnosis
- Lenvatinib (Lenvima)
- Lenvima
- Leukaemia (US Leukemia)
- Levoketoconazole (Recorlev)
- Levothyroxine
- Lipase
- Liquid biopsy
- Liver
- Liver directed therapy
- Liver embolization
- Liver metastases
- Loperamide hydrochloride
- Low Grade NETs
- Lu 177 dotatate
- Lu-177
- Lung Cancer
- Lung NETs
- Lung nodules
- Lutathera
- Luteinizing hormone (LH)
- LUTIA clinical trial
- Lymph nodes
- Lymphadenectomy
- Lymphatic system
- Lymphedema
- Lymphoma
M
- Magnetic resonance imaging (MRI) scan
- Malabsorption
- Malignant
- Mammalian Target of Rapamycin (mTOR)
- Mammalian target of rapamycin (mTOR) inhibitor
- Mammogram
- MANEC
- Marcaine
- Mast cell
- Mastocytosis
- MDH2
- Medical food
- Medicines and Healthcare Products Regulatory Agency
- Medicines and Healthcare products Regulatory Agency (MHRA)
- Medullary thyroid cancer (MTC)
- Melanoma
- Melatonin
- MEN1 syndrome
- MEN2 syndrome
- MEN2A syndrome
- MEN2B syndrome
- MEN4 syndrome
- Meningioma
- Menopause
- MENX
- Merkel cell carcinoma
- Mesenteric root
- Mesentery
- Metanephrines
- Metasasis
- Metastatic Neuroendocrine Cancer
- Metronidazole
- MIBG scan
- Microsatellite instability-high (MSI-H)
- Midgut
- Mineral
- Misdiagnosis
- Mitotic count
- Mitotic rate
- Mixed Neuroendocrine Non-Neuroendocrine Neoplasms (MiNEN)
- Molecular markers
- Monoamine oxidase inhibitors (MAOIs)
- Monoclonal antibodies
- MTD201
- mTOR inhibitor
- Multi tyrosine kinase inhibitors (TKIs)
- Multidisciplinary team (MDT)
- Multikinase inhibitor
- Multimodal treatment
- Multiple Endocrine Neoplasia (MEN)
- Multiple myeloma
- MYCAPSSA®
- Myeloma
N
- Naproxen
- National Cancer Institute
- National Institute for Health and Care Excellence (NICE)
- National Institutes of Health
- Nausea
- Neoplasm
- NET Cancer Day
- NET Centre of Excellence
- NET syndromes
- NETDetect
- NETest
- NETSPOT
- NETTER-1
- NETTER-2
- Neuroblastoma
- Neuroendocrine
- Neuroendocrine cancer
- Neuroendocrine carcinoma (NEC)
- Neuroendocrine neoplasm (NEN)
- Neuroendocrine tumour (NET)
- Neurofibromatosis type 1 (NF1)
- Neurokinin A (NKA)
- Neuropeptide K
- Neurotensin
- Neurotransmitter
- Nexium
- NF1
- NHS
- Niacin
- Night sweat
- Nivolumab (Opdivo)
- Nizatidine
- NKA
- No evidence of disease (NED)
- No-Carrier-Added Lutetium-177 (n.c.a. Lu177)
- Nodule
- Noid
- Non-functional tumour
- Non-small cell lung cancer (NSCLC)
- Noradrenaline
- Norepinephrine
- North American Neuroendocrine Tumor Society (NANETS)
- Novocaine
- NT-proBNP
- Nuclear medicine
- Nutrition
- Nutrizym
O
- Octreoscan (Octreotide scan)
- Octreotide
- Octreotide (Octreotide acetate)
- Octreotide scan
- Octreotide soak
- Octreotide-RP
- Ocular Rosacea
- Omega 3
- Omeprazole
- Omeprazole and sodium bicarbonate
- ONC201
- Oncologist
- Oncolytic virus
- Ondansetron (Zofron)
- Opdivo (Nivolumab)
- Osteoblastic activity
- Osteoporosis
- Ovarian cancer
- Ovarian NEN
- Overactive thyroid
- Overdiagnosis
- Oxaliplatin (Eloxatin)
- Oxitriptan
- Oxytocin
P
- Paclitaxel (Taxol)
- Palliative care
- Palliative treatment
- Palpitation
- Pancreas
- Pancrease
- Pancreastatin
- Pancreatic adenocarcinoma
- Pancreatic cancer
- Pancreatic enzyme replacement therapy (PERT)
- Pancreatic insufficiency
- Pancreatic NET (PanNET)
- Pancreatic polypeptide (PP)
- Pancreatic pseudocyst
- Pancreatic uncinate process
- Pancreatin
- Pancreatogenic diabetes
- Pancreoprivic diabetes
- Pancrex
- Pantoloc control
- Pantoprazole
- Papillary thyroid cancer
- Papulopustular (acne) rosacea
- Paraganglia
- Paraganglioma
- Paraneoplastic syndromes
- Parathyroid gland
- Parathyroid hormone (PTH)
- Parathyroid NET
- Parotid gland NET
- Partial remission
- Pasireotide
- Patent foramen ovale (PFO)
- Pathology
- PD-1/PD-L1 Inhibitors
- PDR001
- Pellagra
- Pembrolizumab (Keytruda)
- Pemetrexed disodium
- PEN-221
- Pentetreotide
- Pepcid (Famotidine)
- Peptide
- Peptide receptor radionuclide therapy (PRRT)
- Peripheral Serotonin
- Peritoneal carcinomatosis
- Pernicious anaemia
- PET Scan
- Pheochromocytoma
- Physician
- Physiological uptake
- PI3K inhibitor
- Pituitary gland
- Pituitary NET (PitNET)
- Plasma 5HIAA
- Platelet-derived growth factor receptor (PDGFR)
- Pleural Fibrosis
- pNET
- Poorly differentiated
- Post operative seroma
- PPoma
- PRCRT
- Pre-existing condition
- Prediabetes
- Pressor amines
- Prevacid (Lansoprazole)
- Prevalence
- Prilosec (Omeprazole)
- Probiotic
- Prognosis
- Progressive cancer
- Proinsulin
- Proliferative rate
- Prostaglandin
- Prostate Cancer
- Protease
- Proteasome inhibitors
- Protein kinase inhibitor
- Proton beam therapy
- Proton pump inhibitors (PPI)
- Protonix (Pantoprazole)
- PRRT
- Pruritus
- Pseudomyxoma peritonei (PMP)
- Pulmonary embolism
- Pulmonary fibrosis
- Pustule
- PV-10
R
- Rabeprazole (Aciphex)
- RADIANT
- Radiation therapy
- Radio Frequency Ablation (RFA)
- Radioactive iodine
- Radioembolization
- Radioimmunotherapy
- Radiolabelled somatostatin analogue
- Radionuclide
- Radiopeptide
- Radiotherapy
- Ranitidine (Zantac)
- Rash
- RB1
- RECORLEV (levoketoconazole)
- Rectal cancer
- Rectal NET
- Red blood count (RBC)
- Remission
- Renal cell carcinoma (RCC)
- Renal insufficiency
- RET
- Retroperitoneal Fibrosis
- Retroperitoneum
- Rhinophyma
- Right hemicolectomy
- Rosacea
- Rose Bengal
S
- Sandostatin
- Sapanisertib
- SARTATE™
- Satoreotide (Lutetium-177 OPS-201)
- SB NET
- Scan
- Scanxiety
- SCF node
- Scleroderma
- SDHA
- SDHAF2
- SDHAF2(SDH5)
- SDHB
- SDHC
- SDHD
- Secretogranin II
- SEER
- Selective Internal Radiotherapy (SIRT)
- Selective Serotonin Reuptake Inhibitor (SSRI)
- Serotonin
- Serotonin and norepinephrine reuptake inhibitor (SNRI)
- Serotonin syndrome
- Serum ferritin
- Serum serotonin
- Setrons
- SI NET
- Side effect
- Siegfried Oberndorfer
- Sigmoidoscopy
- SIGNIFOR® (Pasireotide)
- Skin NET
- Sleep hyperhidrosis
- Small cell lung cancer (SCLC)
- Small cell neuroendocrine carcinoma (SCNEC)
- Small intestine bacterial overgrowth (SIBO)
- Small intestine NET (SI NET)
- Solid tumour
- Solucin ®
- SOM230
- SomaKit TOC
- Somatoprim
- Somatostatin
- Somatostatin analogues
- Somatostatin receptor scintigraphy (SRS)
- Somatostatin receptors (SSTR)
- Somatostatinoma
- Somatuline Autogel (US: depot)
- Spartalizumab
- SPECT
- Spider Veins
- SPINET
- Splenosis
- Splenunculus
- Squamous cell carcinoma
- SSTR-PET
- St. John’s wort
- Stable cancer
- Stage
- Standardised uptake value (SUV)
- Steatorrhea
- Stem Cell
- Stereotactic body radiotherapy (SBRT)
- Stereotactic radiosurgery (SRS)
- Sternoclavicular joint
- Stomach cancer
- Stomach cramp
- Stomach ulcer
- Streptozotocin (Zanosar)
- Stress
- Subpectoral lymph node
- Substance K
- Substance P
- Succinate Dehydrogenase Subunit Genes (SDHx)
- Sulfatinib
- Sunitinib (Sutent)
- Superior mesenteric artery
- Superior mesenteric vein
- Supplements
- Supraclavicularfossa
- Supraclavicularfossa (SCF) lymph nodes
- Surgeon
- Surgery
- Surufatinib
- Surveillance
- Survivor
- Survivorship
- Sweating
- Sweet’s syndrome
- Symptom
- Syndrome
T
- Tachycardia
- Tachykinin
- Tagamet
- Targeted alpha-emitter therapy (TAT)
- Targeted therapy
- TAS-102
- Tecentriq (Atezolizumab)
- Technetium-99m (Tc-99m)
- Telangiectasia
- Telotristat ethyl (Xermelo)
- Temozolomide (Temodal)
- Terminal cancer
- Terminal ileum
- Testicular cancer
- Testosterone
- Tetracycline
- The 5 E’s
- Theranostics
- Thorson-Bioerck syndrome
- Thymic NEN
- Thyroid
- Thyroid cancer
- Thyroid NET
- Thyroid stimulating hormone (TSH)
- Thyroiditis
- Thyroxine (T4)
- Tidutamab
- TNM staging system
- TOCscan®
- Total gastrectomy
- Total pancreatectomy
- TP53
- TPH1
- TPH2
- Transarterial chemo embolization (TACE)
- Transarterial embolizaton (TAE)
- Transarterial radioembolization (TARE)
- Tricyclic antidepressant
- Triglycerides
- Triiodothyronine (T3)
- Tryptophan
- Tryptophan hydroxylase (TPH)
- Tuberous sclerosis (TS)
- Tumor board
- Tumour (Tumor)
- Tumour marker
- Tumour mutational burden (TMB)
- Type 1 diabetes
- Type 2 diabetes
- Type 3c diabetes
- Type 3c diabetes mellitus (T3cDM)
- Typical lung NET
- Tyramine
- Tyrosine kinase inhibitor (TKI)
V
- Vaccine
- Vanillylmandelic acid (VMA)
- Vascular
- Vascular disrupting agent (VDA)
- Vascular endothelial growth factor (VEGF)
- Vasoactive amines
- Vasoactive intestinal peptide (VIP)
- Vasoactive peptides
- Vasodilation
- Vepesid)
- Verner-Morrison syndrome
- Vertebral haemangioma
- Vimovo
- VIPoma
- Vitamin A
- Vitamin ADEK
- Vitamin B complex
- Vitamin B1
- Vitamin B12
- Vitamin B2
- Vitamin B3
- Vitamin B5
- Vitamin B6
- Vitamin B7
- Vitamin B9
- Vitamin C
- Vitamin D
- Vitamin E
- Vitamin K
- Von Hippel-Lindau (VHL) Syndrome
- Von Recklinghausen’s disease
W
#
- 111In-DTPA-D-Phe1
- 123I-Metaiodobenzylguanidine (mIBG)
- 131I-Metaiodobenzylguanidine (mIBG)
- 177Lu OPS 201
- 177Lu-DOTA-EB-TATE
- 177Lu-Edotreotide (Solucin®)
- 177Lu-PSMA-R2
- 18F-FDG
- 18F-FDOPA
- 212Pb-AR-RMX
- 212Pb-AR-RMX
- 225Ac
- 24-hour urinary catacholamines and metanephrines
- 5-Fluorouracil (5-FU)
- 5-HIAA
- 5-HT
- 5-HT3
- 5-HT3-RA
- 5-HTP
- 5-Hydrotryptophan (5-HTP)
- 5-Hydroxyindoleacetic Acid (5-HIAA)
- 5-Hydroxytryptamine (5-HT)
- 64Cu-DOTATATE
- 64Cu-SARTATE
- 67Cu-SARTATE
- 68Ga edotreotide (TOCscan®)
- 68Ga-PSMA-R2
Please note I’m working on the repository throughout 2021 to clean up all definitions, adding and removing links where necessary and ensuring all definitions are linked to at least one article. Where a definition is not yet linked to an article, the definition will still be listed and you will see a message saying “nothing found” and offering you a search of my entire website.
Thanks for supporting this repository.
Ronny
Can’t see the definition you’re looking for? Or is there a broken link? Have a problem with the meaning given? Please contact me using the form below to request an add or update.